Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

5.43
Delayed Data
As of Aug 26
 +0.12 / +2.26%
Today’s Change
4.21
Today|||52-Week Range
9.69
-24.58%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close5.31
Today’s open5.41
Day’s range5.29 - 5.54
Volume28,495
Average volume (3 months)65,351
Market cap$151.3M
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+4.41%
Earnings growth (this year)-12.42%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.62%
P/E ratioNM
Price/Sales3.78
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd-0.08-1.24%
TRILTrillium Therapeutic...-0.25-1.93%
VRMLVermillion Inc+0.01+0.76%
OXFDOxford Immunotec Glo...+0.07+0.68%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$49.5M
Annual profit (last year)-$33.7M
Net profit margin-68.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs